Cargando…

Cardiovascular safety of lumiracoxib: a meta-analysis of randomised controlled trials in patients with osteoarthritis

PURPOSE: To re-evaluate the cardiovascular risk of lumiracoxib compared with other non-steroidal anti-inflammatory drugs (NSAIDs) or placebo in patients with osteoarthritis. METHODS: We conducted a meta-analysis of randomised controlled trials of lumiracoxib versus placebo or other NSAIDs in patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mackenzie, Isla S., Wei, Li, MacDonald, Thomas M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548096/ https://www.ncbi.nlm.nih.gov/pubmed/22732767 http://dx.doi.org/10.1007/s00228-012-1335-1

Ejemplares similares

Lumiracoxib: the evidence of its clinical impact on the treatment of osteoarthritis
por: Profit, Louise, et al.
Publicado: (2007)

A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients
por: Stricker, Kirstin, et al.
Publicado: (2008)

Nitric oxide and cardiovascular effects: new insights in the role of nitric oxide for the management of osteoarthritis
por: Mackenzie, Isla S, et al.
Publicado: (2008)

Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT)
por: MacDonald, Thomas M, et al.
Publicado: (2013)

The effects of lumiracoxib 100 mg once daily vs. ibuprofen 600 mg three times daily on the blood pressure profiles of hypertensive osteoarthritis patients taking different classes of antihypertensive agents
por: MacDonald, T M, et al.
Publicado: (2010)

Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: A randomised controlled trial in patients with osteoarthritis
por: Fleischmann, Roy, et al.
Publicado: (2008)

Efficacy of Etoricoxib, Celecoxib, Lumiracoxib, Non-Selective NSAIDs, and Acetaminophen in Osteoarthritis: A Mixed Treatment Comparison
por: Stam, WB, et al.
Publicado: (2012)

Evaluation of the Patient Acceptable Symptom State in a pooled analysis of two multicentre, randomised, double-blind, placebo-controlled studies evaluating lumiracoxib and celecoxib in patients with osteoarthritis
por: Dougados, Maxime, et al.
Publicado: (2007)

Cluster randomised trials of prescribing policy: an ethical approach to generating drug safety evidence? A discussion of the ethical application of a new research method
por: Rogers, Amy, et al.
Publicado: (2020)

Promoting public awareness of randomised clinical trials using the media: the ‘Get Randomised’ campaign
por: Mackenzie, Isla S, et al.
Publicado: (2010)

Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritis
por: Geusens, Piet, et al.
Publicado: (2008)

Does the provision of a DVD-based audio-visual presentation improve recruitment in a clinical trial? A randomised trial of DVD trial invitations
por: Rogers, Amy, et al.
Publicado: (2019)

Preemptive versus postoperative lumiracoxib for analgesia in ambulatory arthroscopic knee surgery
por: Grifka, Joachim, et al.
Publicado: (2008)

Association between cardiovascular events and sodium-containing effervescent, dispersible, and soluble drugs: nested case-control study
por: George, Jacob, et al.
Publicado: (2013)

Protocol for assessment of sleep quality and duration in the Treatment In Morning versus Evening (TIME) study: a randomised controlled trial using online patient-reported outcome measures
por: Rogers, Amy, et al.
Publicado: (2018)

Impact of allopurinol use on urate concentration and cardiovascular outcome
por: Wei, Li, et al.
Publicado: (2011)

Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study
por: Mackenzie, Isla S, et al.
Publicado: (2016)

First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215]
por: Wittenberg, Ralf H, et al.
Publicado: (2006)

Cluster randomized trials of prescription medicines or prescribing policy: public and general practitioner opinions in Scotland
por: Mackenzie, Isla S., et al.
Publicado: (2012)

Reaching an ACCORD on Glycemia and Systolic Blood Pressure Targets in Type 2 Diabetes Mellitus
por: MacDonald, Thomas M., et al.
Publicado: (2018)

Identifying poor adherence to antihypertensive medications in patients with resistant hypertension
por: Mackenzie, Isla S., et al.
Publicado: (2018)

Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia
por: MacDonald, Thomas M, et al.
Publicado: (2014)

Impact of beta-blockers on mortality and cardiovascular disease outcomes in patients with obstructive sleep apnoea: a population-based cohort study in target trial emulation framework
por: Chen, Anthony, et al.
Publicado: (2023)

Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials
por: Machado, Gustavo C, et al.
Publicado: (2015)

Evaluating Diuretics in Normal Care (EVIDENCE): protocol of a cluster randomised controlled equivalence trial of prescribing policy to compare the effectiveness of thiazide-type diuretics in hypertension
por: Rogers, Amy, et al.
Publicado: (2021)

Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders
por: Coyle, Joanne, et al.
Publicado: (2021)

Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trial
por: MacDonald, Thomas M, et al.
Publicado: (2015)

Ibuprofen and Paracetamol: Acceptably Safe for All?
por: Pigazzani, Filippo, et al.
Publicado: (2018)

Covariance modelling for randomised controlled trials
por: MacKenzie, Gilbert
Publicado: (2013)

Changes in prescribing rates of sodium-containing medications in the UK from 2009 to 2018: a cross-sectional study with interrupted time series analysis
por: Ju, Chengsheng, et al.
Publicado: (2021)

A secondary qualitative analysis of stakeholder views about participant recruitment, retention, and adherence in decentralised clinical trials (DCTs)
por: Coyle, Joanne, et al.
Publicado: (2022)

Evaluating Diuretics in Normal Care (EVIDENCE): a feasibility report of a pilot cluster randomised trial of prescribing policy in primary care to compare the effectiveness of thiazide-type diuretics in hypertension
por: Flynn, Angela, et al.
Publicado: (2022)

Does offering an incentive payment improve recruitment to clinical trials and increase the proportion of socially deprived and elderly participants?
por: Jennings, Claudine G, et al.
Publicado: (2015)

Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study
por: Mackenzie, Isla S, et al.
Publicado: (2012)

Sex differences in adverse events following seasonal influenza vaccines: a meta-analysis of randomised controlled trials
por: Kiely, Marilou, et al.
Publicado: (2023)

Quantifying the real life risk profile of inhaled corticosteroids in COPD by record linkage analysis
por: Flynn, Rob W, et al.
Publicado: (2014)

Factors influencing participation and long-term commitment to self-monitoring of blood pressure in a large remote clinical trial: The treatment in morning versus evening (TIME) study
por: Vickneson, Keeran, et al.
Publicado: (2021)

Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes
por: Mackenzie, Isla S, et al.
Publicado: (2012)

Spironolactone use and risk of incident cancers: a retrospective, matched cohort study
por: Mackenzie, Isla S., et al.
Publicado: (2016)

Home blood pressure monitors owned by participants in a large decentralised clinical trial in hypertension: the Treatment In Morning versus Evening (TIME) study
por: Anbarasan, Thineskrishna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hml89gclfn2cm3ndupjg7i3p6e